A detailed history of Central Trust CO transactions in Atri Cure, Inc. stock. As of the latest transaction made, Central Trust CO holds 35 shares of ATRC stock, worth $1,395. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Previous 35 -0.0%
Holding current value
$1,395
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

SELL
$32.99 - $43.25 $9,798 - $12,845
-297 Reduced 89.46%
35 $1,000
Q3 2023

Oct 26, 2023

BUY
$41.12 - $57.73 $1,439 - $2,020
35 Added 11.78%
332 $14,000
Q3 2022

Nov 17, 2022

SELL
$38.25 - $52.62 $535 - $736
-14 Reduced 4.5%
297 $12,000
Q1 2022

May 03, 2022

BUY
$57.43 - $71.39 $804 - $999
14 Added 4.71%
311 $20,000
Q2 2021

Jul 23, 2021

BUY
$64.13 - $80.18 $19,046 - $23,813
297 New
297 $23,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.85B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.